|
Ruiz-Lafuente N, Minguela A, Moraleda JM, Muro M, Parrado A. Variable Distribution of DOCK-D Proteins between Cytosol and Nucleoplasm in Cell Lines, Effect of Interleukin-4 on DOCK10 in B-Cell Lymphoid Neoplasms, and Validation of a New DOCK10 Antiserum for Immunofluorescence Studies. Antibodies (Basel). 2021 Aug 20;10(3):33. doi: 10.3390/antib10030033. PubMed PMID: 34449554; PubMed Central PMCID: PMC8395434.
AÑO: 2021
|
34449554
|
Alfaro R, Martinez-Banaclocha H, Llorente S, Jimenez-Coll V, Galian JA, Botella C, Moya-Quiles MR, Parrado A, Muro-Perez M, Minguela A, Legaz I, Muro M. Computational Prediction of Biomarkers, Pathways, and New Target Drugs in the Pathogenesis of Immune-Based Diseases Regarding Kidney Transplantation Rejection. Front Immunol. 2021 Dec 15;12:800968. doi: 10.3389/fimmu.2021.800968. eCollection 2021. PubMed PMID: 34975915; PubMed Central PMCID: PMC8714745.
AÑO: 2021; IF: 8.786
|
|
Parrado A. Expression of DOCK10.1 protein revealed with a specific antiserum: insights into regulation of first exon isoforms of DOCK10. Mol Biol Rep. 2020 Apr;47(4):3003-3010. doi: 10.1007/s11033-020-05342-5. Epub 2020 Feb 29. PubMed PMID: 32112301.
AÑO: 2020; IF: 2.316
|
|
Parrado A. Expression of DOCK9 and DOCK11 Analyzed with Commercial Antibodies: Focus on Regulation of Mutually Exclusive First Exon Isoforms. Antibodies (Basel). 2020 Jun 27;9(3):27. doi: 10.3390/antib9030027. PubMed PMID: 32605015; PubMed Central PMCID: PMC7551865.
AÑO: 2020
|
|
Gil-Martinez AL, Cuenca-Bermejo L, Gonzalez-Cuello AM, Sanchez-Rodrigo C, Parrado A, Vyas S, Fernandez-Villalba E, Herrero MT. Identification of differentially expressed genes profiles in a combined mouse model of Parkinsonism and colitis. Sci Rep. 2020 Aug 4;10(1):13147. doi: 10.1038/s41598-020-69695-4. PubMed PMID: 32753609; PubMed Central PMCID: PMC7403295.
AÑO: 2020; IF: 4.379
|